Koyfin Home > Directory > Health Care > Hologic Inc > EBITDA

Hologic Inc EBITDA Chart (HOLX)

Hologic Inc annual/quarterly EBITDA from 1992 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Hologic Inc EBITDA for the quarter ending December 12, 2018 was $261m a 4.67% increase of 12m year over year
  • Hologic Inc EBITDA for the last 12 months ending December 12, 2018 was $1,020m a -1.30% decrease of -13m year over year
  • Hologic Inc Annual EBITDA for 2018 was $1,020m a 1.40% increase of 14m from 2017
  • Hologic Inc Annual EBITDA for 2017 was $1,006m a -3.86% decrease of -39m from 2016
  • Hologic Inc Annual EBITDA for 2016 was $1,045m a 5.06% increase of 53m from 2015
Other Income Statement Metrics:
  • Hologic Inc Net Income for the quarter ending December 12, 2018 was $99m a 791.08% increase of 780m year over year
  • Hologic Inc Total Revenue for the quarter ending December 12, 2018 was $831m a 4.98% increase of 41m year over year
View Chart On Koyfin

Quarterly HOLX EBITDA Data

12/2018$261m
09/2018$222m
06/2018$259m
03/2018$249m
12/2017$259m
09/2017$270m
07/2017$259m
04/2017$219m
12/2016$265m
09/2016$265m

Annual HOLX EBITDA Data

2018$1,020m
2017$1,006m
2016$1,045m
2015$992m
2014$914m
2013$845m
2012$719m
2011$623m
2010$601m
2009$592m